Cadmium (Cd) is a cumulative element with a biological half-life of >10 years in humans. The total amount of Cd accumulated in the liver and in the kidney can be measured in vivo by neutron activation (or x-ray fluorescence), but this technique does not necessarily measure the fraction that is biologically active. At low exposure (i.e., general environmental exposure or moderate occupational exposure), blood Cd is mainly influenced by the last 2 to 3 months of exposure. Under such conditions, the Cd concentration in urine mainly reflects the amount of Cd stored in the body, particularly in the kidney. In Europe and the US, the Cd reference values are usually <2 nmol/mmol creatinine. Because most of the Cd in urine is probably bound to metallothionein, the changes in the urinary metallothionein concentration parallel those of Cd. The determination of Cd concentration in hair is of limited value because in humans it is difficult to distinguish between externally deposited and endogenous Cd. Fecal Cd is a good indicator of the oral daily intake. The results of several cross-sectional epidemiologic studies of the relation between the prevalence of renal dysfunctionand Cd concentration in urine led us to propose a biological limit value for Cd of 5 and 2 nmol/mmol creatinine for adult male workers and the general population, respectively.
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The metabolism of cadmium (Cd) has been reviewed recently (1). Exposure of the nonsmoking general population to Cd is mainly through food, whereas for smokers tobacco is also an important source of Cd exposure. In the occupational setting, inhalation of Cd-containing dust and fumes is the major route of uptake. The oral absorption rate is in the 2-7% range, with values of up to 20% for subjects with very low iron stores. A puhnonary absorption rate of 25-50% has been estimated for Cd oxide fumes. The absorption of other Cd compounds may vary greatly, depending on the chemical species and the particle size. Of circulating Cd, >90% is bound to erythrocytes.
Cd is a cumulative element with a biological half-life of >10 years in man. It accumulates mainly in the kidney and in the liver, with -50% of the body burden in these two organs. In the general population the concentration of Cd in the kidney increases progressively with age at least until age 50-60, and then tends to decline. Liver concentration does not show a clear de- In tissues, Cd is bound mainly to metallothionein, whose production is stimulated by Cd exposure. Cd is excreted via the urine and to a smaller extent through the bile, the gastrointestinal tract, saliva, hair, nails, and breast milk.
In man, the three main targets after long-term Cd exposure are lung, bone, and kidney, but it is generally accepted that the kidney is the critical organ, i.e., the organ that exhibits the first adverse effects (1 
Cd in Blood
Blood Cd concentration is influenced by both the body burden and recent exposure, but several observations in the general population, in workers moderately exposed to Cd, and also experimental data suggest that Cd in blood mainly reflects the last few months of exposure. In newly exposed workers, the Cd concentration increases progressively for 4-6 months and then levels off at a value that is proportional to the average intensity of exposure (3). Reduction of exposure intensity is associated with a progressive decline of the Cd concentration in blood (half-time 2-3 months). However, in subjects who have been highly exposed in the past and have accumulated large amounts of Cd, the body burden may play a significant role in determining the concentration in blood (4) . 
Metallothionein in Urine
Because most of the Cd in urine is probably bound to metallothionein, the changes in the urinary metallothionein concentration parallel those of Cd. Before the occurrence of renal tubular damage, the urinary concentration of metallothionein is mainly an indicator of Cd body burden (10).
Cd in Hair
Cd accumulated in hair reflects the concentration of the metal in blood during the growth phase of the hair. However, this analysis is of limited value because in humans it is very difficult to distinguish between endogenous Cd and Cd externally deposited on the hair (11).
Cd in Feces
Fecal Cd is a good indicator of the daily amount of Cd ingested via food and the amount cleared from the lungs (1). In practice, however, it is more complicated to get access to feces than to blood and urine.
From (12) (13) (14) (15) (16) . We also noted that an increased gbmerular permeability, reflected by an increased excretion of high-molecular-mass proteins, could also be detected in some Cd workers who did not present signs of tubular dysfunction.
In the framework of a recent collaborative European Community project, we examined a cohort of workers exposed to Cd and a matched control group for the presence of early renal changes. Several biologic markers were used to detect changes at different renal sites (glomerulus, proximal tubule, loop of Henle, distal tubule, and interstitium).
A multiple regression analysis revealed a significant association between the Cd concentration in urine and the urinary output of several markers
(17).

Four thresholds of urinary
Cd were identified (Table  1) 5-year prospective study on Cd workers led us to conclude that the Cd-induced low-molecular-mass proteinuria, which may occur when Cd in urine exceeds 10 nmol/mmol creatinine, should be regarded as an adverse effect because it is irreversible (18) We conclude that environmental exposure to Cd in certain areas of Belgium may induce slight renal tubular dysfunction and may probably also affect calcium homeostasis.
The probability of occurrence of tubular dysfunction significantly exceeds the background concentration when Cd in urine reaches 2 nmolJmmol creatinine. This value should be regarded as the maximum tolerable internal dose of Cd for the general population. This concentration corresponds to a renal cortex concentration of -50 ppm. In view of our knowledge of the toxicokinetics of Cd, we estimate that in nonsmokers, this concentration is attained after 50 years of an oral daily intake of Cd of -1 'ug/kg body weight.
